Novartis India has agreed to acquire the Indian trademarks and related intellectual property for Pfizer's Minipress brand for ₹12.5 billion, or approximately $140 million, in a substantial addition to its portfolio of established medicines. Despite the Novartis name, the transaction is no longer an acquisition by Swiss pharmaceutical company Novartis AG....
Goldman Sachs Invested in India’s Aragen Life Sciences
In May 2021, Manhattan, NY-headquartered Goldman Sachs alternative investing arm Goldman Sachs Asset Management acquired a significant minority stake in Hyderabad, India-based Aragen Life Sciences a contract research organization. Goldman bought shares previously held by ChrysCapital and other existing shareholders who were invested in the company for more than five...